NASDAQ:TRAX | News | First Tracks Biotherapeutics, Inc.

TRAX News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-12Current reportSEC filingFirst Tracks Biotherapeutics, Inc. filed Form 8-KFirst Tracks Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-06-22Current reportSEC filingFirst Tracks Biotherapeutics, Inc. filed Form 8-KFirst Tracks Biotherapeutics, Inc. filed Form 8-K covering items 1.01.
2026-05-14Current reportSEC filingFirst Tracks Biotherapeutics, Inc. filed Form 8-KFirst Tracks Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-04-20Current reportSEC filingFirst Tracks Biotherapeutics, Inc. filed Form 8-KFirst Tracks Biotherapeutics, Inc. filed Form 8-K covering items 1.01,2.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01.
2026-04-03Current reportSEC filingFirst Tracks Biotherapeutics, Inc. filed Form 8-KFirst Tracks Biotherapeutics, Inc. filed Form 8-K covering items 7.01,9.01.